Kyntra Bio, Inc. (KYNB) — Net Asset Quality Index
Kyntra Bio, Inc. (KYNB) has a Net Asset Quality Index of -28.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $109.63 Million minus total liabilities of $140.40 Million yields net assets of $-30.77 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see KYNB company net worth.
Quality Index
Net Assets
Total Assets
Total Liabilities
Kyntra Bio, Inc. Net Asset Quality Index Over Time (2012–2025)
This chart shows how Kyntra Bio, Inc.'s Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at -28.1%, representing net assets of $-30.77 Million against total assets of $109.63 Million USD. See KYNB net asset value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Kyntra Bio, Inc. (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Kyntra Bio, Inc. from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check KYNB strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 3.7% | $4.47 Million | $119.59 Million | $115.12 Million | ▲ +89.3 pp |
| 2024 | -85.6% | $-183.63 Million | $214.53 Million | $398.16 Million | ▼ -47.3 pp |
| 2023 | -38.3% | $-162.20 Million | $423.53 Million | $585.73 Million | ▼ -38.1 pp |
| 2022 | -0.2% | $-1.48 Million | $610.09 Million | $611.57 Million | ▼ -29.9 pp |
| 2021 | 29.6% | $229.11 Million | $773.82 Million | $544.71 Million | ▼ -23.8 pp |
| 2020 | 53.4% | $441.45 Million | $826.84 Million | $385.39 Million | ▼ -9.1 pp |
| 2019 | 62.4% | $535.41 Million | $857.40 Million | $321.99 Million | ▲ +2.4 pp |
| 2018 | 60.0% | $528.47 Million | $880.60 Million | $352.13 Million | ▼ -4.8 pp |
| 2017 | 64.8% | $582.45 Million | $898.65 Million | $316.20 Million | ▲ +27.5 pp |
| 2016 | 37.3% | $175.11 Million | $469.55 Million | $294.44 Million | ▼ -4.5 pp |
| 2015 | 41.8% | $196.82 Million | $470.57 Million | $273.75 Million | ▼ -7.9 pp |
| 2014 | 49.8% | $240.68 Million | $483.53 Million | $242.85 Million | ▲ +13.5 pp |
| 2013 | 36.2% | $107.60 Million | $296.95 Million | $189.35 Million | ▼ -9.8 pp |
| 2012 | 46.0% | $122.18 Million | $265.59 Million | $143.40 Million | — |